Donald Trump's ambitious plan to overhaul the wasteful federal government is rapidly becoming mired in the 'lawfare' that plagued his first administration. Elon Musk's Department of Government ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...